About 55% of Canadians are covered by employer-sponsored drug plans, which means that when these workers get laid off, they also lose their health benefits, including prescription drug insurance tied to their jobs.
Novo Nordisk announces Health Canada has granted priority review status for once-weekly semaglutide to treat metabolic dysfunction-associated steatohepatitis.
A panel of dermatologists develops core principles, consensus statements and a treatment algorithm for the management of atopic dermatitis with topical products.